Synthesis and biological activity of 5-aza-ellipticine derivatives
Novel 5-aza-ellipticine derivatives were synthesized and tested as antitumor agents. The new compounds were prepared more readily than the analogous ellipticine derivatives, which are known to be potent anti-tumor agents Although the novel 5-aza-ellipticine derivatives are not as biologically active...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2007-04, Vol.17 (8), p.2380-2384 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2384 |
---|---|
container_issue | 8 |
container_start_page | 2380 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 17 |
creator | Moody, Deborah L. Dyba, Marcin Kosakowska-Cholody, Teresa Tarasova, Nadya I. Michejda, Christopher J. |
description | Novel 5-aza-ellipticine derivatives were synthesized and tested as antitumor agents. The new compounds were prepared more readily than the analogous ellipticine derivatives, which are known to be potent anti-tumor agents Although the novel 5-aza-ellipticine derivatives are not as biologically active as their corresponding ellipticine analogues, the new compounds represent a new, readily accessible class of heteroaromatic catalytic inhibitors of topoisomerase II and possible anti-tumor agents. |
doi_str_mv | 10.1016/j.bmcl.2006.09.093 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2262287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X06011632</els_id><sourcerecordid>19519616</sourcerecordid><originalsourceid>FETCH-LOGICAL-c580t-38528ef6c36295c2c4a3a83a0f8c21ec93b6c5d3c0f3e731c3c4119f20ce78873</originalsourceid><addsrcrecordid>eNp9kE1vEzEQhi1ERUPhD3BAe6G3Tf21XltCSFBBi1SJA1TqzXJmZ9uJNutgbyKlvx6HRBQuSCP5MM-8M34YeyP4XHBhLpbzxQqGueTczLkrpZ6xmdBG10rz5jmbcWd4bZ2-O2Uvc15yLjTX-gU7Fa1qjWntjH36vhunB8yUqzB21YLiEO8JwlAFmGhL066KfdXU4THUOAy0nghoxKrDRNtQCMyv2Ekfhoyvj-8Zu_3y-cfldX3z7err5cebGhrLp1rZRlrsDSgjXQMSdFDBqsB7C1IgOLUw0HQKeK-wVQIUaCFcLzlga22rztiHQ-56s1hhBzhOKQx-nWgV0s7HQP7fzkgP_j5uvZRGyt8B58eAFH9uME9-RRnKr8KIcZO9cI1wRpgCygMIKeacsP-zRHC_V--Xfq_e79V77kqpMvT27_OeRo6uC_DuCIRcBPcpjED5ibOmsUq7wr0_cFhkbgmTz0A4AnaUECbfRfrfHb8AqGKjaA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19519616</pqid></control><display><type>article</type><title>Synthesis and biological activity of 5-aza-ellipticine derivatives</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Moody, Deborah L. ; Dyba, Marcin ; Kosakowska-Cholody, Teresa ; Tarasova, Nadya I. ; Michejda, Christopher J.</creator><creatorcontrib>Moody, Deborah L. ; Dyba, Marcin ; Kosakowska-Cholody, Teresa ; Tarasova, Nadya I. ; Michejda, Christopher J.</creatorcontrib><description>Novel 5-aza-ellipticine derivatives were synthesized and tested as antitumor agents. The new compounds were prepared more readily than the analogous ellipticine derivatives, which are known to be potent anti-tumor agents Although the novel 5-aza-ellipticine derivatives are not as biologically active as their corresponding ellipticine analogues, the new compounds represent a new, readily accessible class of heteroaromatic catalytic inhibitors of topoisomerase II and possible anti-tumor agents.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2006.09.093</identifier><identifier>PMID: 17376678</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>5-Aza-ellipticine ; Anti-tumor agents ; Antineoplastic agents ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - pharmacology ; Aza Compounds - chemical synthesis ; Aza Compounds - pharmacology ; Biological and medical sciences ; Cell Line ; Cell Survival - drug effects ; Ellipticine ; Ellipticines - chemical synthesis ; Ellipticines - pharmacology ; General aspects ; Humans ; Inhibitory Concentration 50 ; Medical sciences ; Pharmacology. Drug treatments ; Structure-Activity Relationship ; Topoisomerase II ; Topoisomerase II Inhibitors</subject><ispartof>Bioorganic & medicinal chemistry letters, 2007-04, Vol.17 (8), p.2380-2384</ispartof><rights>2006 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c580t-38528ef6c36295c2c4a3a83a0f8c21ec93b6c5d3c0f3e731c3c4119f20ce78873</citedby><cites>FETCH-LOGICAL-c580t-38528ef6c36295c2c4a3a83a0f8c21ec93b6c5d3c0f3e731c3c4119f20ce78873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2006.09.093$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18658349$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17376678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moody, Deborah L.</creatorcontrib><creatorcontrib>Dyba, Marcin</creatorcontrib><creatorcontrib>Kosakowska-Cholody, Teresa</creatorcontrib><creatorcontrib>Tarasova, Nadya I.</creatorcontrib><creatorcontrib>Michejda, Christopher J.</creatorcontrib><title>Synthesis and biological activity of 5-aza-ellipticine derivatives</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Novel 5-aza-ellipticine derivatives were synthesized and tested as antitumor agents. The new compounds were prepared more readily than the analogous ellipticine derivatives, which are known to be potent anti-tumor agents Although the novel 5-aza-ellipticine derivatives are not as biologically active as their corresponding ellipticine analogues, the new compounds represent a new, readily accessible class of heteroaromatic catalytic inhibitors of topoisomerase II and possible anti-tumor agents.</description><subject>5-Aza-ellipticine</subject><subject>Anti-tumor agents</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Aza Compounds - chemical synthesis</subject><subject>Aza Compounds - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>Ellipticine</subject><subject>Ellipticines - chemical synthesis</subject><subject>Ellipticines - pharmacology</subject><subject>General aspects</subject><subject>Humans</subject><subject>Inhibitory Concentration 50</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><subject>Topoisomerase II</subject><subject>Topoisomerase II Inhibitors</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1vEzEQhi1ERUPhD3BAe6G3Tf21XltCSFBBi1SJA1TqzXJmZ9uJNutgbyKlvx6HRBQuSCP5MM-8M34YeyP4XHBhLpbzxQqGueTczLkrpZ6xmdBG10rz5jmbcWd4bZ2-O2Uvc15yLjTX-gU7Fa1qjWntjH36vhunB8yUqzB21YLiEO8JwlAFmGhL066KfdXU4THUOAy0nghoxKrDRNtQCMyv2Ekfhoyvj-8Zu_3y-cfldX3z7err5cebGhrLp1rZRlrsDSgjXQMSdFDBqsB7C1IgOLUw0HQKeK-wVQIUaCFcLzlga22rztiHQ-56s1hhBzhOKQx-nWgV0s7HQP7fzkgP_j5uvZRGyt8B58eAFH9uME9-RRnKr8KIcZO9cI1wRpgCygMIKeacsP-zRHC_V--Xfq_e79V77kqpMvT27_OeRo6uC_DuCIRcBPcpjED5ibOmsUq7wr0_cFhkbgmTz0A4AnaUECbfRfrfHb8AqGKjaA</recordid><startdate>20070415</startdate><enddate>20070415</enddate><creator>Moody, Deborah L.</creator><creator>Dyba, Marcin</creator><creator>Kosakowska-Cholody, Teresa</creator><creator>Tarasova, Nadya I.</creator><creator>Michejda, Christopher J.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20070415</creationdate><title>Synthesis and biological activity of 5-aza-ellipticine derivatives</title><author>Moody, Deborah L. ; Dyba, Marcin ; Kosakowska-Cholody, Teresa ; Tarasova, Nadya I. ; Michejda, Christopher J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c580t-38528ef6c36295c2c4a3a83a0f8c21ec93b6c5d3c0f3e731c3c4119f20ce78873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>5-Aza-ellipticine</topic><topic>Anti-tumor agents</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Aza Compounds - chemical synthesis</topic><topic>Aza Compounds - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>Ellipticine</topic><topic>Ellipticines - chemical synthesis</topic><topic>Ellipticines - pharmacology</topic><topic>General aspects</topic><topic>Humans</topic><topic>Inhibitory Concentration 50</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><topic>Topoisomerase II</topic><topic>Topoisomerase II Inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moody, Deborah L.</creatorcontrib><creatorcontrib>Dyba, Marcin</creatorcontrib><creatorcontrib>Kosakowska-Cholody, Teresa</creatorcontrib><creatorcontrib>Tarasova, Nadya I.</creatorcontrib><creatorcontrib>Michejda, Christopher J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moody, Deborah L.</au><au>Dyba, Marcin</au><au>Kosakowska-Cholody, Teresa</au><au>Tarasova, Nadya I.</au><au>Michejda, Christopher J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and biological activity of 5-aza-ellipticine derivatives</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2007-04-15</date><risdate>2007</risdate><volume>17</volume><issue>8</issue><spage>2380</spage><epage>2384</epage><pages>2380-2384</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Novel 5-aza-ellipticine derivatives were synthesized and tested as antitumor agents. The new compounds were prepared more readily than the analogous ellipticine derivatives, which are known to be potent anti-tumor agents Although the novel 5-aza-ellipticine derivatives are not as biologically active as their corresponding ellipticine analogues, the new compounds represent a new, readily accessible class of heteroaromatic catalytic inhibitors of topoisomerase II and possible anti-tumor agents.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17376678</pmid><doi>10.1016/j.bmcl.2006.09.093</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2007-04, Vol.17 (8), p.2380-2384 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2262287 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | 5-Aza-ellipticine Anti-tumor agents Antineoplastic agents Antineoplastic Agents - chemical synthesis Antineoplastic Agents - pharmacology Aza Compounds - chemical synthesis Aza Compounds - pharmacology Biological and medical sciences Cell Line Cell Survival - drug effects Ellipticine Ellipticines - chemical synthesis Ellipticines - pharmacology General aspects Humans Inhibitory Concentration 50 Medical sciences Pharmacology. Drug treatments Structure-Activity Relationship Topoisomerase II Topoisomerase II Inhibitors |
title | Synthesis and biological activity of 5-aza-ellipticine derivatives |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T03%3A28%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20biological%20activity%20of%205-aza-ellipticine%20derivatives&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Moody,%20Deborah%20L.&rft.date=2007-04-15&rft.volume=17&rft.issue=8&rft.spage=2380&rft.epage=2384&rft.pages=2380-2384&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2006.09.093&rft_dat=%3Cproquest_pubme%3E19519616%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19519616&rft_id=info:pmid/17376678&rft_els_id=S0960894X06011632&rfr_iscdi=true |